BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 18716108)

  • 21. MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations.
    Yagyu Y; Awai K; Inoue M; Watai R; Sano T; Hasegawa H; Nishimura Y
    AJR Am J Roentgenol; 2005 May; 184(5):1535-40. PubMed ID: 15855112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis.
    Guerrisi A; Marin D; Nelson RC; De Filippis G; Di Martino M; Barnhart H; Masciangelo R; Guerrisi I; Passariello R; Catalano C
    Br J Radiol; 2011 Aug; 84(1004):698-708. PubMed ID: 21750137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of optimal scan delay for gadoxetate disodium-enhanced hepatic arterial phase MRI using MR fluoroscopic triggering and slow injection technique.
    Goshima S; Kanematsu M; Kondo H; Watanabe H; Kawada H; Moriyama N; Bae KT
    AJR Am J Roentgenol; 2013 Sep; 201(3):578-82. PubMed ID: 23971449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT.
    Goshima S; Kanematsu M; Noda Y; Kawai N; Kawada H; Ono H; Bae KT
    AJR Am J Roentgenol; 2016 Mar; 206(3):518-25. PubMed ID: 26901007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Split-bolus spectral multidetector CT of the pancreas: assessment of radiation dose and tumor conspicuity.
    Brook OR; Gourtsoyianni S; Brook A; Siewert B; Kent T; Raptopoulos V
    Radiology; 2013 Oct; 269(1):139-48. PubMed ID: 23674791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aortic and hepatic contrast enhancement with abdominal 64-MDCT in pediatric patients: effect of body weight and iodine dose.
    Bae KT; Shah AJ; Shang SS; Wang JH; Chang S; Kanematsu M; Hildebolt CF
    AJR Am J Roentgenol; 2008 Nov; 191(5):1589-94. PubMed ID: 18941106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small hypervascular hepatocellular carcinoma revealed by double arterial phase CT performed with single breath-hold scanning and automatic bolus tracking.
    Kim T; Murakami T; Hori M; Takamura M; Takahashi S; Okada A; Kawata S; Cruz M; Federle MP; Nakamura H
    AJR Am J Roentgenol; 2002 Apr; 178(4):899-904. PubMed ID: 11906869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma.
    Gordic S; Puippe GD; Krauss B; Klotz E; Desbiolles L; Lesurtel M; Müllhaupt B; Pfammatter T; Alkadhi H
    Radiology; 2016 Jul; 280(1):78-87. PubMed ID: 26824712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinomas: correlation between time to peak hepatocellular carcinomas enhancement and time to peak aortic enhancement.
    Sun X; Liu C; Liang C; Sun C; Liu S; Deng K
    Comput Med Imaging Graph; 2009 Jun; 33(4):312-6. PubMed ID: 19303253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Optimal phase of dynamic CT for detecting hypervascular hepatocellular carcinoma: evaluation of double arterial phases].
    Kajiya Y; Kamimura K; Jinguji M; Nakajo M; Tsuchimochi S; Sako K; Komorizono Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Apr; 65(2):99-104. PubMed ID: 15920968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing.
    Mitsuzaki K; Yamashita Y; Ogata I; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 Sep; 167(3):753-7. PubMed ID: 8751695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver by means of helical CT: comparison of different contrast medium concentrations within the same patient.
    Sultana S; Morishita S; Awai K; Kawanaka K; Ohyama Y; Nakayama Y; Imuta M; Arakawa A; Yamashita Y
    Radiat Med; 2003; 21(6):239-45. PubMed ID: 14743896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma.
    Goshima S; Kanematsu M; Kondo H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
    AJR Am J Roentgenol; 2009 Mar; 192(3):686-92. PubMed ID: 19234264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium.
    Hori M; Murakami T; Oi H; Kim T; Takahashi S; Matsushita M; Tomoda K; Narumi Y; Kadowaki K; Nakamura H
    Acta Radiol; 1998 Mar; 39(2):144-51. PubMed ID: 9529444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials.
    Hänninen EL; Vogl TJ; Felfe R; Pegios W; Balzer J; Clauss W; Felix R
    Radiology; 2000 Aug; 216(2):403-9. PubMed ID: 10924561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depiction of hypervascular hepatocellular carcinoma with 64-MDCT: comparison of moderate- and high-concentration contrast material with and without saline flush.
    Matoba M; Kitadate M; Kondou T; Yokota H; Tonami H
    AJR Am J Roentgenol; 2009 Sep; 193(3):738-44. PubMed ID: 19696287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal scan timing for coronal enhancement of hypervascular hepatocellular carcinomas and correlation with tumor size: evaluation with four-phase CT hepatic arteriography.
    Miyamoto N; Sakurai Y; Nishimori H; Tsuji K; Kang JH; Maguchi H
    Radiat Med; 2005 Sep; 23(6):456-62. PubMed ID: 16389992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic contrast-enhanced MDCT of the liver: analysis of the effect of different iodine concentrations with the same total iodine dose in the same chronic liver disease patients.
    Tozaki M; Naruo K; Fukuda K
    Radiat Med; 2005 Dec; 23(8):533-8. PubMed ID: 16555560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late-arterial and portal-venous phase imaging of the liver with a multislice CT scanner in patients without circulatory disturbances: automatic bolus tracking or empirical scan delay?
    Itoh S; Ikeda M; Achiwa M; Satake H; Iwano S; Ishigaki T
    Eur Radiol; 2004 Sep; 14(9):1665-73. PubMed ID: 15067427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spiral CT for the detection of hepatocellular carcinomas:relative value of arterial- and late-phase scanning.
    Choi BI; Cho JM; Han JK; Choi DS; Han MC
    Abdom Imaging; 1996; 21(5):440-4. PubMed ID: 8832866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.